Register
Register
Register

Project cooperationUpdated on 14 January 2026

Connecting Innovation to Cure: Virtual Human Twins Driving the Future of Cancer Research

Grant Writer and Advisor at Research Centre of the Portuguese Oncology Institute of Lisbon Francisco Gentil

Lisbon, Portugal

About

IPO de Lisboa is committed to advancing precision oncology through cutting-edge Virtual Human Twin (VHT) models. As part of the Horizon Europe mission on cancer, we aim to transform patient care by leveraging digital twin technology to predict treatment responses and optimize therapies. We are actively seeking partners to co-develop innovative solutions that accelerate breakthroughs in cancer research.

Our Contribution:
IPO de Lisboa brings unique strengths to this collaboration:

  • Clinical Expertise & Patient Data: Access to real-world oncology data for model development and validation.

  • Research Infrastructure: Advanced facilities for translational cancer research and clinical trials.

  • Validation & Testing: Ability to test VHT models in real clinical settings.

  • Regulatory & Ethical Guidance: Ensuring compliance with EU standards and patient safety.

  • Innovative Concept: A potential idea to create patient-specific digital twins for personalized treatment planning and improved outcomes.

Stage

  • Design - setting the project scope

Topic

  • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research

Type

  • Consortium/Coordinator seeks Partners

Similar opportunities